Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02229968
PHASE2

Efficacy of Amicar for Children Having Craniofacial Surgery

Sponsor: Children's National Research Institute

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine whether Amicar (ε-aminocaproic acid) is effective in reducing blood loss in children undergoing craniofacial reconstruction surgery. The investigators hypothesize that Amicar will decrease intraoperative blood loss and decrease the need for perioperative blood product administration in children undergoing craniofacial surgery.

Official title: Efficacy of ε-Aminocaproic Acid (EACA) in Children Undergoing Craniofacial Reconstruction Surgery

Key Details

Gender

All

Age Range

2 Months - 36 Months

Study Type

INTERVENTIONAL

Enrollment

22

Start Date

2014-10

Completion Date

2028-03

Last Updated

2026-04-07

Healthy Volunteers

No

Interventions

DRUG

Amicar (ε-aminocaproic acid)

DRUG

normal saline

Locations (1)

Vanderbilt University Medical Center

Nashville, Tennessee, United States